CHICAGO Dec. 16, 2021 – 

AMOpportunities today announced the closing of their Series A2 at $2 million. The Chicago-based startup is a pioneer in clinical-training-as-a-service (“CTaaS”), managing clinical training for schools, hospitals, and students globally. 

To date, this brings the company’s total capital funding to nearly $9 million. AMO experienced accelerated growth in 2021, highlighting the relevance of its service offering in the marketplace and creating the need to expand the organization ahead of schedule. Given AMO’s growth, the Series A2 was an up round, increasing AMO’s valuation. The company graduates from venture capital to join OCA Venture’s growth equity fund. 

“This funding comes at the cusp of an inflection point that we believe will bring AMO to our next stage of growth,” says Ben Bradley, COO. “Investor interest in this round exceeded our wildest expectations because of the hard work that our team put in every day—pushing the company through COVID and coming out stronger on the other side.” 

Supportive of AMO’s growth trajectory, OCA Ventures, PACE Healthcare and Dreamit Ventures all contributed to the round. 

 “We have been impressed by AMO’s business model and the whole team—both from professional and personal experience,” says Julia Monfrini Peev, managing partner at PACE Healthcare Capital. 

Julia’s husband, now a board-certified surgeon, had previously gone through the nuts and bolts of clinical training in the U.S. It made her realize that “the sector was begging for innovative solutions. AMO is the only company that has been able to turn clinical training into a tailored, quality service. The overall industry is excited about AMO’s unique service offering and the company is poised for strong growth. We could not have been more excited to reinvest.” 

With this new funding, AMO will invest in staffing, technology, and hospital recruitment, allowing the company to acquire the supply needed to meet the demand for clinical training from students and graduates around the world. 

Medical students, nurses and healthcare workers need hands-on clinical training to graduate. Until AMO, the process to access quality rotations was complex, opaque, and sometimes arbitrary—for U.S. students, and even more so for international students. Now quality rotations are just a click away on AMO’s platform. 

Hospitals have rallied in mass to join AMO’s platform. Due to staffing shortages, student recruitment issues, and an inability to monetize rotations, hospitals have historically struggled to provide enough spots to meet with demand. 

Now AMO alleviates the burden from hospitals by handling the administrative work needed to select and host students; providing student support; offering a centralized location for applications, trainees, program information, and document collection; and sourcing students directly from partnered medical schools, ensuring high-quality trainees. 

Additionally, hosting students allows hospitals to diversify their future residency pipeline by increasing the exposure of their residence programs to a large base of potential residents. 

Finally, hospitals are now able to monetize their time for training students, with an earning potential of more than $1 million per hospital. 

2022 will see AMO continue to develop partnerships with hospitals and global medical schools, build out the company’s SaaS platform, and expand teaching opportunities at hospitals across the country.  


About AMOpportunities, Inc.  

AMOpportunities, Inc. is a Chicago-based company that manages clinical training for schools, hospitals, and students globally. The company’s clinical training as a service platform has provided more than 3,500 students with rotations at 250-plus clinical sites. They count Kaplan Medical and AMSA as partners as well as institutions such as University of Miami, UChicago Medicine, MedStar Georgetown University Hospital, Florida International University, and UI Health. 

For more information about AMOpportunities, visit 


About PACE Healthcare Capital 

PACE Healthcare Capital is an early-stage venture capital firm focused on investing in companies that have developed high impact solutions to critical healthcare challenges. With decades of combined experience and $1B+ of capital raised and deployed in healthcare, we apply institutional-grade investment processes to identify the best entrepreneurs, and deploy financial and human capital to help them grow their business.   

Find out more at